The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients

NCT05289986 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class

Stopped The CI, sponsor and funder jointly made the decision to end the trial due to lack of recruitment, as well as due to delays it was felt value of the primary endpoint had lessened to a point where its scientific value was questioned.

Conditions

Interventions

Sponsor

Chelsea and Westminster NHS Foundation Trust

Collaborators